Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis by Metkar, Sunil S. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/03/875/11 $8.00
The Journal of Cell Biology, Volume 160, Number 6, March 17, 2003 875–885
http://www.jcb.org/cgi/doi/10.1083/jcb.200210158
 
JCB
 
Article
 
875
 
Granzyme B activates procaspase-3 which signals a 
mitochondrial ampliﬁcation loop for maximal apoptosis
 
Sunil S. Metkar,
 
1
 
 Baikun Wang,
 
1
 
 Michelle L. Ebbs,
 
1
 
 Jin H. Kim,
 
2
 
 Yong J. Lee,
 
2
 
 Srikumar M. Raja,
 
1
 
 
and Christopher J. Froelich
 
1
 
1
 
Evanston Northwestern Healthcare Research Institute, Feinberg School of Medicine, Northwestern University, Evanston, IL 60201
 
2
 
Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260
 
ranzyme B (GrB), acting similar to an apical
caspase, efﬁciently activates a proteolytic cascade
after intracellular delivery by perforin. Studies here
were designed to learn whether the physiologic effector,
GrB–serglycin, initiates apoptosis primarily through cas-
pase-3 or through BH3-only proteins with subsequent
mitochondrial permeabilization and apoptosis. Using four
separate cell lines that were either genetically lacking
the zymogen or rendered deﬁcient in active caspase-3,
we measured apoptotic indices within whole cells (ac-
tive caspase-3, mitochondrial depolarization [
 
  
 
m] and
TUNEL). Adhering to these conditions, the following were
observed in targets after GrB delivery: (a) procaspase-3–
deﬁcient cells fail to display a reduced 
 
  
 
m and DNA
G
 
fragmentation; (b) Bax/Bak is required for optimal 
 
  
 
m
reduction, caspase-3 activation, and DNA fragmentation,
whereas BID cleavage is undetected by immunoblot; (c) Bcl-2
inhibits GrB-mediated apoptosis (reduced 
 
  
 
m and TUNEL
reactivity) by blocking oligomerization of caspase-3; and (d)
in procaspase-3–deﬁcient cells a mitochondrial-independent
pathway was identiﬁed which involved procaspase-7 activa-
tion, PARP cleavage, and nuclear condensation. The data
therefore support the existence of a fully implemented apop-
totic pathway initiated by GrB, propagated by caspase-3,
and perpetuated by a mitochondrial ampliﬁcation loop
but also emphasize the presence of an ancillary caspase-
dependent, mitochondria-independent pathway.
 
Introduction
 
Cytotoxic T lymphocytes and natural killer (NK)* cells induce
apoptosis in target cells by two mechanisms: engagement of
the Fas (CD95) receptor on target cells and delivery of the
cytotoxic granule constituents. Ligation of the Fas receptor
recruits a signaling complex to the inner leaflet of the target
cell membrane resulting in the processing of procaspase-8.
The granule secretion pathway appears to require the direct
intracellular delivery of a family of granule-associated serine
proteases, granzymes, which activate caspase-dependent and
-independent death programs to ensure target cell demise.
Among the granule proteases, granzyme B (GrB) serves as
a model to understand how intracellular delivery of a protease
causes cell death (Barry and Bleackley, 2002). GrB shares
substrate specificity with caspases for cleavage after aspartate
residues (Poe et al., 1991) and has been reported to process
numerous caspases in vitro including caspase-3, -6, -7, -8
and -10 (Darmon et al., 1995; Chinnaiyan et al., 1996;
Duan et al., 1996; Talanian et al., 1997). The results have
lead to the notion that the protease initiates death by pro-
cessing any number of caspases in vivo (Medema et al.,
1997; Barry et al., 2000). We have learned, however, that
GrB, due to the constraints of accessibility and rates of pro-
teolysis proceeds efficiently in vivo to first process caspase-3,
which along with GrB then matures caspase-7 (Yang et al.,
1998). On this basis, we have come to view GrB as apical
caspase-like in function. We have nonetheless speculated
that GrB might also have the capacity to initiate alternate
death pathways if the caspase cascade is paralyzed, for example,
by viral inhibitors (Talanian et al., 1997). Supporting this
concept, GrB appears to process certain caspase substrates
including PARP, NuMA, DNA-PK (Andrade et al., 1998),
and DFF45/inhibitor of caspase-activated deoxyribonuclease
(ICAD) (Thomas et al., 2000; Sharif-Askari et al., 2001)
and thus might cause cell death independently of the
caspases. In contradistinction to the activation of a pro-
teolytic cascade by an intracellularly delivered protease, GrB
has been reported to induce death through a mitochondria-
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centered pathway by cleaving the BH3-only proapoptotic
Bcl-2 family member, Bid. Three groups have reported data
linking rapid Bid proteolysis with mitochondrial permeabili-
zation (MacDonald et al., 1999; Heibein et al., 2000; Sut-
ton et al., 2000; Alimonti et al., 2001; Pinkoski et al., 2001),
suggesting the granzyme induces death primarily through
this pathway.
Mitochondrial membrane permeabilization may be medi-
ated by cytosolic factors such as Bax/Bak which insert in
the outer membrane. Alternately, changes in the mitochon-
drial permeability transition pore complex (Bernardi, 1999;
Crompton, 2000b) may allow the release of intramembra-
nous proteins and/or loss of membrane potential across
the inner membrane (
 
  
 
m) (Bernardi, 1999; Crompton,
2000a; Loeffler and Kroemer, 2000). The outer mitochon-
drial membrane, responding to proapoptotic signals, be-
comes permeabilized and releases factors such as cytochrome
c (cyt c), apoptosis-inducing factor (Joza et al., 2001; Ye et
al., 2002), and most recently the serine protease HtrA2/Omi
(Suzuki et al., 2001) and endonuclease G (Hengartner,
2001; Li et al., 2001). Among these paradigms, GrB-gener-
ated truncated Bid is predicted to oligomerize with proapop-
totic family members, Bax and/or Bak, forming large ion
channels in the outer mitochondrial membranes. The re-
leased cyt c then coalesces into an apoptosome with Apaf-1
and dATP facilitating activation of caspase-9, which in turn
processes caspase-3 (Li et al., 1997; Zou et al., 1997). GrB
also has been predicted to induce apoptosis by directly per-
turbing mitochondrial integrity through a Bid-independent
pathway (Alimonti et al., 2001). Finally, using lines defi-
cient in Bid, Bax, and/or Bak, investigators have shown GrB
readily induces mitochondrial depolarization independently
of cyt c release, permeability transition, and caspase activa-
tion (Thomas et al., 2001). Together the results imply the
granzyme has a multifaceted potential to ensure target cell
death by initiating several pathways: (a) caspase driven, (b)
BH3-only protein driven, (c) directly “damaging” mito-
chondria, and (d) cleavage of crucial structural and regula-
tory proteins.
We have reported that GrB is exclusively secreted from cy-
totoxic cells as a macromolecular complex bound to chon-
droitin sulfate proteoglycan, serglycin (SG) (Metkar et al.,
2002), and have provided the biophysical basis for this ob-
servation (Raja et al., 2002). The use of free GrB could lead
potentially to anomalous binding of the granzyme to anionic
membranes on the target cell surface and cytosolic proteins.
As a consequence, we thought it would be instructive to re-
assess how the granzyme initiates death after intracellular de-
livery of the macromolecular complexes. Using techniques
that examine apoptotic events in situ, we report here that
GrB–SG initiates death predominantly through caspase-3,
and mitochondria secondarily amplify this process.
 
Results
 
Adventitious processing of Bid in GrB-treated targets
 
GrB has been reported to cleave Bid initiating a mitochon-
drial apoptotic pathway. The experimental design which
served as the basis for these observations involved immuno-
blotting cytosolic extracts from solubilized targets. Targets
exposed to GrB contain protease localized to the endosomes
and plasma membrane. Solubilization liberates sequestered
granzyme, allowing adventitious cleavage of cytosolic/nu-
clear substrates which might otherwise be inaccessible dur-
ing granzyme delivery by either perforin (PFN) or endoso-
molytic agents (Froelich et al., 1996a). Our intent was to
confirm that GrB-mediated cleavage of Bid indeed occurred
after intracellular delivery of the granzyme rather than dur-
ing solubilization. Therefore, we evaluated the processing of
this key proapoptotic component under conditions de-
signed to inhibit the granzyme during solubilization (see
Materials and methods) and, in parallel, examined whether
the caspases might contribute to Bid cleavage As shown in
Fig. 1 A, the delivery of GrB–SG complexes to MCF-7
 
wt
 
and MCF-7
 
casp-3
 
 cells did not produce the anticipated cleav-
age of Bid despite the assurance that adenovirus (AD) was
capable of endosomolysis (see Materials and methods) and
caspase-3 cleavage was observed by immunoblotting in
MCF-7
 
casp-3
 
 cells (Fig. 1 B).
We then examined whether the removal of the inhibitor
during target cell solubilization might result in BID cleav-
age (Yang et al., 1998). MCF-7
 
vec
 
 cells were exposed to
GrB–SG complexes for 30 min at 37
 
 
 
C. The cells were
washed, incubated in the presence or absence of inhibitor
(IETD-CHO, 250 
 
 
 
M) for 20 min, and then solubilized
with buffer in the presence or absence of additional inhibi-
tor. Blockade of GrB activity in the lysates exposed to
IETD-CHO was verified using the chromogenic substrate,
IETD-pNA (unpublished data). The lysates were prepared
for electrophoresis and subsequent blotting followed by re-
action with anti-Bid and anti–caspase-7 antibodies. The lat-
ter was chosen because it is not substantially processed in
MCF-7
 
wt
 
 cells during short term assays (Yang et al., 1998)
but is rapidly cleaved in vitro and thus might be processed
despite efforts to minimize proteolysis during the solubiliza-
tion step. Generation of lysates without the granzyme in-
hibitor resulted in almost an immediate and complete pro-
cessing of both caspase-7 and Bid (Fig. 1 C). A similar
outcome was also noted for Jurkat cells (unpublished data).
Bid appears to be available for processing by GrB during
target cell solubilization but remains sequestered from the
granzyme in whole cells when proteolysis of the BH3 pro-
tein is evaluated by immunoblotting. To learn whether the
inaccessibility of Bid is a general attribute of MCF-7 cells
undergoing apoptosis, we then evaluated processing of the
BH3 protein during death receptor–induced apoptosis. The
MCF-7
 
wt
 
 and MCF-7
 
casp-3
 
 cells were treated with recombi-
nant Trail and processing of Bid was evaluated. Unlike
GrB-mediated killing, engagement of the TRAIL receptor
resulted in the partial disappearance of Bid (Fig. 1 D), indi-
cating that Bid is accessible to proteolysis during death re-
ceptor–mediated apoptosis.
Observing prominent adventitious processing in GrB-
treated cells after solubilization, we speculated that a similar
outcome might occur when lysates are generated after
whole cell cytotoxicity assays. Using the NK-lymphoma cell
line YT, which lacks detectable Bid as a surrogate effector
and Jurkat cells as target, the cells were mixed at a 1:1 ratioT
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Figure 1. Processing of Bid after GrB delivery. (A) Bid is not cleaved in either MCF-7Vec or MCF-7Casp-3 cells after GrB–SG delivery. 
MCF-7Vec (top) or MCF-7Casp-3 cells (bottom) were treated as shown and probed for Bid cleavage. Cells were incubated as follows: media 
(lane 1), GrB–SG (lane 2), AD (lanes 3), or GrB–SG   AD for 15 min (lanes 4), 60 min (lanes 5), 120 min (lanes 6), or 240 min (lanes 7). 
Afterwards, cells were solubilized in the presence of IETD-cho as describe in Materials and methods, and the postnuclear lysates were 
run on 15% SDS-PAGE gels. Results are representative of one of three independent experiments. (B) Procaspase-3 is cleaved in MCF-7Casp-3 
cells after GrB delivery. Cells were in media, GrB–SG, or AD for 15 min, or targets underwent delivery of GrB–SG for 15, 60, 120, or 240 
min. The cells were solubilized in the presence of IETD-cho as described in Materials and methods and processed for immunoblotting 
with anti–caspase-3 antibody. Results are representative of one of three independent experiments. (C) MCF-7Vec cells were incubated 
with media (lane 1), GrB (lanes 2 and 3), or GrB–SG (lanes 4 and 5) for 30 min at 37 C to allow endocytosis of the granzyme. The cells 
were then washed three times and incubated with PBS (lanes 2 and 4) or 250  M IETD-cho (lanes 3 and 5) for 20 min (37 C). Thereafter, 
cells in lanes 3 and 5 were solubilized in lysis buffer containing IETD-cho (250  M). The postnuclear lysates (10  g) were run on 15% 
SDS-PAGE gels, transferred, and probed with either anti–caspase-7 (top) or anti-Bid (bottom) antibodies. (D) Bid is cleaved after death 
receptor ligation in both MCF-7Vec or MCF-7Casp-3 cells. Cells were treated with 200 ng/ml TRAIL for the times shown (1–3 h). Lysates 
(20  g) were separated by SDS-PAGE and immunoblotted with anti-Bid or antiactin antibody. (E) A model for artifactual processing of 
Bid during effector target cytotoxicity. One million YT NK lymphoma cells were used as effectors with Jurkat serving as targets (E:T  
1:1). The effectors and targets were mixed with either PBS (top) or IETD-cho (250  M) (bottom) as described in the legend to Fig. 2 B and 
then lysed in either the absence (top) or presence (bottom) of additional IETD-cho (250  M). The lysate was then allowed to stand for 0, 
5, 15, 30, and 60 min at 37 C after which Laemmli buffer was added. The lysates (10  g) were then heated, loaded on a 15% SDS-PAGE, 
blotted, and probed with anti-Bid antibody. The first lane shows a Jurkat lysate control, whereas the last is the YT control.  -Tubulin 
served as a loading control.T
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and solubilized in the presence and absence of IETD-cho.
After incubation for various times (0–60 min), the lysates
were blotted and probed with anti-Bid antisera. In the ab-
sence of the inhibitor, there was complete processing of Bid
at the earliest measurable time (Fig. 1 E). In presence of
IETD-cho, disappearance of the 22-kD Bid was observed
but only after 60 min, a time when the effect of the inhibi-
tor likely is exhausted. Together the results indicate that
precautions are necessary to distinguish intracellular and
postlytic proteolysis (i.e., adventitious processing) during
GrB-induced apoptosis assays if treated targets require solu-
bilization. In addition, the reported cleavage of Bid dur-
ing GrB-mediated cell death appears to be due to adventi-
tious proteolysis, suggesting the mechanism(s) responsible
for granzyme-mediated mitochondrial disruption remains
largely unexplained.
 
Bax/Bak (
 
 
 
/
 
 
 
) MEFs undergo less mitochondrial 
potential loss after GrB–SG delivery than WT MEFs
 
Although we failed to identify processed Bid in MCF-
7
 
(vec/casp3)
 
 cells, mitochondrial disruption via a GrB-initiated
mechanism could still occur through a Bax/Bak-dependent
pathway (Wei et al., 2001) or independently of BH3
domain proteins (Alimonti et al., 2001; Thomas et al.,
2001). To investigate whether Bax and Bak contributed
to a granzyme-initiated apoptotic cascade, double negative
(DKO) Bax 
 
 
 
 Bak (
 
 
 
/
 
 
 
) murine embryonic fibroblasts
(MEFs) were studied for their sensitivity to granzyme-medi-
ated mitochondrial disruption and cell death.
To avoid adventitious processing and the difficulties in-
herent to interpreting the significance of cleaved proteins
observed by immunoblot, we limited our examination for
signs of cell death to intact cells. Furthermore, we observed
Figure 2. Bax and Bak are crucial for GrB–SG-associated mitochondrial depolarization. (A) WT and DKO (Bax   Bak 
 / ) MEFs show 
comparable TUNEL staining during GrB-mediated apoptosis. Cells were treated with GrB–SG at 2  g/ml and AD for 4 h at 37 C and analyzed 
for TUNEL reactivity. Results represent mean values from three experiments. Similar results were obtained for delivery of free GrB (unpublished 
data). (B) DKO MEFs show a reduced elevation of caspase-3 activity compared with WT MEFs. Cells were treated as described in the legend 
to Fig. 2 A for 5–120 min, and the percentage of cells with active caspase-3 were measured using FAM-DEVD-FMK on a flow cytometer. 
Results are representative of the mean   SE of three experiments. (C) DKO MEFs show less mitochondrial potential loss than WT MEFs. Cells 
were treated as described in the legend to Fig. 2 A, and the percentage of loss in mitochondrial potential was determined with CMX-ROS dye 
and flow cytometry. Results are representative of mean   SE of three experiments. (D) DEVD-fmk and ZVAD-fmk inhibit mitochondrial 
potential loss in WT MEFs. WT MEFs were preincubated with media, DMSO, or DEVD-fmk and ZVAD-fmk (100  M) for 30 min at 37 C and 
then treated with GrB or GrB–SG   AD for 1 h, and the percentage of cells with a loss in mitochondrial potential was measured using the 
CMX-ROS dye and flow cytometry. Results are representative of the mean   SE of three experiments. (E) DEVD-fmk and ZVAD-fmk completely 
inhibit mitochondrial potential loss in DKO MEFs. DKO MEFs were preincubated with media, DMSO, or DEVD-fmk and ZVAD-fmk (100  M) 
for 30 min at 37 C and then treated with GrB or GrB–SG   AD for 4 h at 37 C followed by determination of cells with loss in mitochondrial 
potential. The percentage of cells with   m is shown as the mean   SE of three experiments.T
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that the granzyme variably detached the MEFs and thereby
might obscure the results by causing anoikis. To minimize
this confounding variable, MEFs were proteolytically de-
tached for the described treatment periods. Focusing first on
the nuclear aspect of the apoptotic response, the Bax/Bak
(
 
 
 
/
 
 
 
) MEFs showed a reduced level of DNA fragmenta-
tion by TUNEL staining at 2 h which was then comparable
to wild type (WT) at 4 h (Fig. 2 A). After determining that
Bax/Bak (
 
 
 
/
 
 
 
) and WT MEFs contained comparable levels
of activatable procaspase-3 (unpublished data), kinetics of
intracellular active caspase-3 formation and mitochondrial
potential loss (
 
  
 
m) were investigated. The Bax/Bak (
 
 
 
/
 
 
 
)
MEFs showed lower levels of active caspase-3 throughout
the kinetic analysis (Fig. 2 B). Finally, the rate and level of
mitochondrial potential loss was less in DKO than WT cells
being imperceptible in one experiment (Fig. 2 C).
Previous investigations have suggested that a blockade in
caspase activation does not prevent GrB-mediated mito-
chondrial disruption in a variety of cell lines and Bax/Bak
(
 
 
 
/
 
 
 
) cells (Heibein et al., 2000; Sutton et al., 2000; Ali-
monti et al., 2001; Thomas et al., 2001). Efficacy of caspase
inhibition has either relied on showing the designated inhib-
itor blocks cell death by another stimulus (e.g., death recep-
tor ligation) (Sutton et al., 2000) or minimizes activation of
protease activity measured spectrophotometrically in crude
lysates (Thomas et al., 2001). The former approach may be
invalid due to differences in the level of active caspase
achieved in each experimental system, whereas the latter ap-
proach tends to underestimate the level of active caspase due
to the nonspecific inhibitory effects of the complex protein
content of the lysate (unpublished data). To circumvent the
liabilities of these approaches, we used intact GrB-treated
cells and the PhiPhiLux assay to determine the molar con-
centration of inhibitors that block caspase-3 activation in
situ. For the MEFs, both the relatively caspase-3 specific in-
hibitor, DEVD-fmk, and the broad spectrum inhibitor,
VAD-fmk (100 
 
 
 
M), were necessary to ensure reproducible
blockade (unpublished data). We then investigated whether
caspases contributed to mitochondrial potential loss in the
WT and Bax/Bak (
 
 
 
/
 
 
 
) MEFs undergoing granzyme deliv-
ery (Fig. 2, D and E). When either WT or Bax/Bak (
 
 
 
/
 
 
 
)
MEFs were pretreated with these inhibitors and then sub-
jected to granzyme delivery with AD, mitochondrial poten-
tial loss was no longer apparent (Fig. 2, D and E) and apop-
tosis, as defined by DNA strand breakage, was absent
(unpublished data). The results therefore suggest that cas-
pases mediate the mitochondrial depolarization during GrB-
mediated apoptosis and this process is divisible into a BH3/
Bax/Bak-dependent and BH3-independent pathway.
 
Caspase-3 is essential for mitochondrial potential loss 
and DNA fragmentation
 
The preceding results suggest that prevention of GrB-medi-
ated caspase-3 activation protects against mitochondrial dis-
ruption and nuclear signs of apoptosis. However, due to the
conflicting data surrounding this observation the results
warranted verification in cells that absolutely lacked pro-
caspase-3. To directly examine the role of caspase-3 in GrB-
mediated mitochondrial dysfunction, we evaluated alter-
ations in MCF-7 cells lacking procaspase-3 (MCF-7
 
vec
 
) and
a stable transfectant expressing the zymogen (MCF-7
 
casp-3
 
)
(Yang et al., 1998). Despite the apparent absence of Bid
cleavage in MCF
 
casp-3
 
 cells (Fig. 1 A), mitochondrial poten-
tial loss was clearly observed at 15 min in these cells, whereas
 
  
 
m remained intact in MCF-7
 
vec
 
 cells lacking procas-
pase-3 (Fig. 3 A). The MCF-7
 
vec
 
 cells also failed to develop
TUNEL reactivity for upwards to 20 h after GrB delivery,
whereas MCF-7
 
casp-3
 
 cells displayed substantial DNA frag-
mentation at 4 h (Fig. 3 B). As expected, intracellular active
Figure 3. Caspase-3 is required for mitochondrial potential loss 
and DNA fragmentation. (A) Mitochondrial potential loss does not 
occur in MCF-7 cells lacking procaspase-3. MCF-7Vec and MCF-7Casp-3 
cells were treated with GrB–SG and AD for the indicated times, and 
mitochondrial potential loss was analyzed by CMX-ROS staining. 
Results are representative of the mean   SE of three experiments. 
Similar results were obtained for delivery of free GrB (unpublished 
data). (B) MCF-7 cells lacking caspase-3 do not undergo DNA 
fragmentation after GrB delivery. MCF-7Vec– or MCF-7casp-3–transfected 
cells were treated as indicated for either 6 or 20 h at 37 C and 
analyzed for TUNEL reactivity. Results are representative of the 
mean   SE of three experiments. Similar results were obtained for 
delivery of free GrB (unpublished data). (C) PARP is cleaved in 
caspase-3–deficient cells after GrB–SG delivery. MCF-7Vec cells 
were subject to GrB–SG delivery in the presence and absence of 
ZVAD-fmk/DEVD-fmk (100  M) for the times indicated followed by 
solubilization and immunoblotting with anti-PARP antibody.T
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caspase-3 was discernible from analysis of lysates within
15 min of GrB delivery in MCF
 
casp-3
 
 (unpublished data),
whereas processed procaspase-3 was observed later by immu-
noblotting (60 min) (see above and Fig. 1 B).
The combined results suggest that active caspase-3 is re-
sponsible for mitochondrial potential loss during GrB-medi-
ated apoptosis. However, the data do not exclude a role for
caspase-7. On the basis of immunoblot analysis, caspase-3
acts jointly with GrB to rapidly process caspase-7 after
granzyme delivery (Yang et al., 1998). Therefore, the ab-
sence of caspase-3 in MCF-7
 
vec
 
 cells could preclude effective
activation of caspase-7 and thereby prevent the initiation of
molecular events disrupting mitochondria. To determine the
potential contribution of caspase-7, we devised the following
strategy. As described above, MCF-7
 
vec
 
 cells fail to demon-
strate a reduction in 
 
  
 
m after granzyme delivery. We asked
whether active caspase-7 might be present in MCF-7
 
vec
 
 cells
and if detected would indicate the caspase does not contrib-
ute to the detected mitochondrial disruption (Lassus et al.,
2002). In the absence of a specific fluorogenic substrate for
caspase-7, this issue was addressed indirectly by determining
whether PARP, a substrate processed by caspase-7 (Germain
et al., 1999), was cleaved to its signature apoptotic fragment
in cells lacking procaspase-3. Indeed, PARP appeared to be
processed in MCF-7
 
vec
 
 cells, an effect inhibited by VAD-
fmk/DEVD-fmk (Fig. 3 C). The observation thus suggests
that sufficient procaspase-7 may be directly activated by GrB
to cleave PARP but the caspase does not appear to contribute
to mitochondrial potential loss.
 
Bcl-2 suppresses GrB–SG-mediated caspase-3 
activation followed by mitochondrial membrane 
potential loss and DNA fragmentation
 
Among the findings reported in cells undergoing apoptosis
in the presence of purified GrB, perhaps the most consistent
observation is the capacity of Bcl-2 to prevent cell death.
The results here show that GrB first activates caspase-3 and
this or a related family member then contributes to the loss
in mitochondrial membrane potential and DNA fragmenta-
tion. Since Bcl-2 has been reported to minimize activation
of caspase-3 (Krebs et al., 1999), we asked whether Bcl-2
might inhibit GrB-associated mitochondrial depolarization
by preventing the activation of caspase-3. Using a Jurkat cell
line as a model, we examined how overexpression of Bcl-2
influenced mitochondrial membrane potential, intracellular
caspase activation, and DNA fragmentation after granzyme
delivery. As a prelude to these studies, we documented that
recombinant Bcl-2 does not directly inhibit the enzymatic
activity of either soluble GrB or active caspase-3 (unpub-
lished data). Bcl-2–transfected Jurkat cells (Jurkat
 
Bcl-2
 
) were
Figure 4. Resistance of Bcl-2–transfected Jurkat cells to GrB–SG is due to a block in caspase-3 activation. (A) Caspase-3 activation is 
blocked in Bcl-2–transfected Jurkat cells. Jurkatvec or JurkatBcl-2 were treated with GrB–SG and AD for the indicated times (5–120 min), and the 
percentage cells with active caspase-3 enumerated by flow cytometry. Results are representative of the mean   SE of three experiments. 
Similar results were obtained for delivery of free GrB (unpublished data). (B) Mitochondrial potential loss is substantially inhibited in Jurkat 
cells overexpressing Bcl-2. Jurkatvec or JurkatBcl-2 were treated with GrB–SG and AD for the indicated times (5–120 min), and the percentage of 
cells with reduction in mitochondrial potential was enumerated. Results are representative of the mean   SE of three experiments. Similar 
results were obtained for delivery of free GrB (unpublished data). (C) DNA fragmentation is significantly inhibited in Jurkat cells overexpressing 
Bcl-2. Cells were treated as described in Fig. 4 A for 4 h, fixed, and stained for TUNEL. The percentage of cells with increased TUNEL 
reactivity are shown. Results are representative of the mean   SE of three experiments. Similar results were obtained for delivery of free GrB 
(unpublished data). (D) Cleavage of caspase-3 in cells overexpressing Bcl-2. Jurkatvec or JurkatBcl-2 were treated with media (lane 1), GrB–SG 
(lane 2), AD (lane 3), or GrB–SG  AD for 5 min (lane 4), 15 min (lane 5), 45 min (lane 6), or 120 min (lane 7) and lysed in the presence 
of IETD-cho. The postnuclear lysates were run on 15% SDS-PAGE gels and probed for caspase-3. Results are representative of one of two 
independent experiments.T
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then found to show a substantial inhibition of caspase-3 ac-
tivity compared with the control (Fig. 4 A); a result paral-
leled by the caspase-3 fluorogenic assay performed on cell ly-
sates (unpublished data). In comparison, mitochondrial
potential loss and DNA fragmentation were also markedly
reduced in JurkatBcl-2 cells (Fig. 4, B and C). Finally, despite
the virtual absence of activated caspase-3 in Bcl-2–trans-
fected cells, processed procaspase-3 could be detected by im-
munoblotting (Fig. 4 D). Together the results reinforce the
concept that mitochondria are undisturbed after granzyme
delivery if the level of active caspase-3 is minimized and,
Bcl-2, at least during GrB-induced killing, acts by prevent-
ing the activation of caspase-3.
Discussion
The studies performed here were designed to learn whether
GrB–SG complexes initiate cell death pathways through the
caspases as well as through the recently reported capacity of
granzyme to cleave Bid with subsequent mitochondrial per-
meabilization. To this end, we used three separate cell lines
that were either genetically lacking or rendered caspase-3 de-
ficient and focused on measurements of apoptotic indices
within whole cells (active caspase-3 levels, changes in   m
and TUNEL). Finally, when immunoblotting was necessary
we used approaches that minimized adventitious proteolysis
in solubilized granzyme-loaded cells. Adhering to these
conditions, we observed the following in cells undergoing
granzyme delivery: (a) Bid cleavage is not readily detected by
immunoblotting; (b) the majority of the mitochondrial de-
polarization appears dependent on the presence of Bax/Bak,
but DNA fragmentation may occur in the absence of the cell
death amplification loop; (c) procaspase-3–deficient MCF-7
cells do not display a reduction in   m or evidence of
DNA fragmentation; and (d) Bcl-2 appears to inhibit GrB-
mediated apoptosis, as measured by reduced   m and
TUNEL reactivity, by blocking activation of caspase-3. Fi-
nally, the majority of the data was generated with GrB–SG
complexes as death effectors. Similar results were obtained
for all experiments with free GrB (unpublished data), elimi-
nating the possibility that the data was skewed by usage of
the complexes.
Several laboratories have reported that GrB apparently
cleaves Bid in situ; an event associated with the reduction in
  m and cyt C release. When performed with targets
treated with caspase inhibitors, the combined result of Bid
cleavage and persistent mitochondrial disruption has been
interpreted to indicate the granzyme initiates death through
a mitochondria-centered, caspase-independent pathway. We
emphasize that the reliability of these interpretations are
hampered by the lack of safeguards to block GrB-associated
adventitious proteolysis which could yield spurious immu-
noblot and cyt c release data and to ensure caspases are inac-
tivated in GrB-treated cells.
Solubilization of targets exposed to GrB release seques-
tered granzyme allowing cleavage of susceptible substrates.
Among the proteins processed by GrB perhaps the two most
readily cleaved are Bid and procaspase-7. We first recognized
this problem of adventitious proteolysis during studies per-
formed to delineate the sequence of caspases processed after
delivery of free GrB (Yang et al., 1998). In the absence of
controls exposed to GrB alone and a strategy to inactivating
the granzyme immediately before and during solubilization,
immunoblot data that compared rates of processing of
caspase-3 and -7 would be interpreted to indicate that
caspase-7 is processed first after GrB delivery. Therefore, it is
not surprising that Bid has been considered a key substrate
through which GrB apparently activates a mitochondrial
death pathway and that homogenates from GrB-treated cells
contain released cyt c. Notably, a similar outcome may occur
during whole cell cytotoxicity assays (Thomas et al., 2001)
(Fig. 1 E), and the use of PFN at permeabilizing concentra-
tions also could produce anomalous proteolysis due to diffu-
sion of the granzyme into necrotic but otherwise intact cells.
Despite the lack of proof that Bid is a dominant initiator
of a mitochondrial death pathway, available data indicate
that mitochondria play a crucial role in GrB-mediated apop-
tosis. Unlike cytochrome release assays, which are hampered
by the lack of safeguards against adventitious proteolysis,
support for GrB-dependent disruption of mitochondrial in-
tegrity is based more reliably on studies which examine
changes in mitochondrial membrane potential and the de-
tection of released cyt c in whole cells by imaging techniques
(Pinkoski et al., 2001; Thomas et al., 2001). What has been
uncertain is whether mitochondrial depolarization occurs
primarily via BH3-only/Bax/Bak pathway and whether the
granzyme directly mediates these effects or participates indi-
rectly via one or more of the caspases.
Studies in Bax/Bak MEFs have shown that almost every
described form of cell death requires the presence of these
proteins (Wei et al., 2001). Therefore, existence of Bax/Bak-
dependent and -independent pathways during GrB-medi-
ated apoptosis is most reliably assessed with Bax/Bak ( / )
MEFs. In comparison to a previous report (Thomas et al.,
2001), we observed that the predominate reduction of   m
occurred in WT, and only a minor alteration was observed
in Bax/Bak ( / ) MEFs. The disparate observations may
be due to differences in the techniques used to deliver the
granzyme and the confounding effect GrB-mediated detach-
ment may have on mitochondrial depolarization.
Until now, caspases have not been considered crucial for
GrB-mediated mitochondrial disruption in a variety of cell
lines (Heibein et al., 2000; Sutton et al., 2000; Alimonti et
al., 2001; Thomas et al., 2001). We suggest the major rea-
son for this discrepancy rests on whether caspases were com-
pletely inhibited in the respective studies. Unlike the forms
of cells death where caspases undergo controlled autoactiva-
tion via protein–protein interactions, the cytosolic delivery
of GrB presents the pool of procaspases with a renewable ac-
tivator that is only exhausted once the granzyme is blocked
by cognate inhibitors (e.g., PI-9). This, we suspect, is the ba-
sis for the greater difficulty encountered in blocking the
caspase cascade in GrB-treated cells (Talanian et al., 1997).
Although the study of cells deficient in key caspases (see be-
low) offers a more satisfactory approach, we believed it was
crucial to examine cells which lacked Bax/Bak and active
caspase-3 to determine whether the granzyme directly dis-
rupts mitochondrial integrity. We had relied previously on
measuring caspase activity colorimetrically in lysates after
preincubation with the designated inhibitors (Talanian etT
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al., 1997). However, the level of activated caspase-3 in solu-
bilized cells is reduced in the presence of cell lysates (unpub-
lished data), resulting in an underestimation of the active
protease intracellularly. To circumvent this problem, we ver-
ified the effectiveness of the caspase inhibitors in whole cells
using the PhiPhiLux assay (Komoriya et al., 2000). Relying
on the combination of DEVD-fmk and VAD-fmk, mito-
chondrial depolarization was blocked in WT cells, suggest-
ing caspases rather than GrB were responsible.
To decisively establish that caspases play a central role in
mitochondrial depolarization during GrB-mediated apopto-
sis, we then showed that   m only occurred in targets con-
taining procaspase-3 (e.g., MCF-7casp3 cells). Notably, similar
results were obtained with procaspase-3 ( / ) MEFs (un-
published data), indicating the observation is not cell type
specific. Coupled with the observation that   m was more
reduced in WT than DKO MEFs, the results indicate that
the predominant GrB death pathway starts with intracellular
delivery of the granzyme, continues with activation of pro-
caspase-3, and is followed by caspase-mediated engagement of
a BH3-only/Bax/Bak pathway. The BH3-only protein that is
cleaved by caspase-3 is unclear. In other systems, caspase-3
has been reported to process BID, amplifying the death pro-
cess (Slee et al., 2000). As observed for caspase-7 where the
active protease was undetected by blotting but seemed appar-
ent by PARP cleavage, more sensitive assays may reveal that
BID is processed to amplify GrB-mediated apoptosis. How-
ever, at present the mechanism underlying GrB-initiated,
caspase-3–mediated engagement of the Bax/Bak pathway
may be implemented by BID or other BH3-only proteins.
Consistent with data presented here that Bid may not be crit-
ical for GrB induced apoptosis, it has been shown recently
that the GrB cleavage site in Bid is not conserved among dif-
ferent species which are known to have granzyme-laden cyto-
toxic T lymphocytes (Coultas et al., 2002).
Since caspase-3 and -7 are rapidly processed during GrB-
induced apoptosis (Yang et al., 1998), it was unclear
whether both proteases contribute to the observed reduction
in   m. Despite our inability to detect processed caspase-7
by immunoblotting in MCF-7vec cells during a 4-h assay
(Yang et al., 1998), the results suggests GrB can directly acti-
vate this caspase after intracellular delivery. This interpreta-
tion is supported by evidence that PARP is similarly cut by
both caspase-3 and -7 (Germain et al., 1999) and by data
here, which indicates PARP cleavage in MCF-7vec cells is in-
hibited by DEVD-fmk (Fig. 3 E). Therefore, although pro-
cessed caspase-7 was not apparent in procaspase-3–deficient
cells by immunoblotting, GrB appears to access and activate
this procaspase. Furthermore, sufficient active caspase-7 is
generated to cleave PARP and yet a reduction in   m does
not occur. Together, the results suggest that caspase-7 does
not disrupt mitochondrial function. Furthermore, MCF-7vec
cells do not show signs of DNA fragmentation by TUNEL
upwards to 20 h after GrB delivery (unpublished data), but
Hoechst staining reveals that most MCF-7vec cells contained
condensed nonfragmented nuclei (unpublished data). Con-
sistent with a recent observation (Marsden et al., 2002),
caspase-7 directly activated by GrB may be sufficient to in-
duce apoptosis and thus represent a unique death pathway
which is entirely independent of mitochondria.
The WT MEFs clearly produced higher levels of active
caspase-3 than DKO MEFs. This observation may provide
clues as to how mitochondria amplify GrB-mediated apop-
tosis. Since the cell-associated procaspase-3 does not appear
to be completely activated in DKO cells, a portion of the zy-
mogen may be sequestered from the granzyme. Procaspase-3
has been reported to reside in mitochondrial (Mancini et al.,
1998) and cytosolic compartments. Therefore, with mito-
chondrial permeabilization the zymogen leaves the mito-
chondria and becomes accessible to processing by the
granzyme. However, recent evidence cast doubts on the lo-
calization of procaspase-3 to mitochondria (van Loo et al.,
2002). Therefore, coupled with the observation that cytoso-
lic procaspase-3 is compartmentalized to free and mem-
brane-bound fractions (Krebs et al., 1999), a plausible alter-
native entails the generation of an amplification loop where
caspase-9 rather than GrB activates the membrane-associ-
ated procaspase-3 zymogen.
Using Bcl-2–transfected cells, we verify previous studies
which showed that the antiapoptotic protein protects targets
from GrB-mediated death (Sutton et al., 1997; Pinkoski et
al., 2001). However, the results here establish that Bcl-2 acts
at the most proximal aspect of the granzyme-mediated death
pathway by inhibiting the activation of caspase-3. Despite the
marked reduction in active caspase-3 within cells, the pro-
cessed subunits were identified by immunoblot (Fig. 4 D), an
observation we made previously in targets undergoing GrB-
induced apoptosis in the presence of DEVD-fmk (Talanian et
al., 1997). However, isolated Bcl-2 does not directly inhibit
the proteolytic activity of caspase-3 (unpublished data). To-
gether, the results suggest that Bcl-2 interferes with oligomer-
ization of the caspase into active heterodimers. We thus
identify a novel mechanism through which the potent antiap-
optotic protein prevents cell death (Cory and Adams, 2002)
akin to the described Bcl-2–associated sequestration of BH3-
only domain proteins (Cheng et al., 2001).
Combining three separate strategies to ablate procaspase-3
function with three assays that focus on intracellular events in
whole cells, the results indicate that GrB initiates death by ac-
tivating procaspase-3 rather than by modifying BH3-only
proteins (Heibein et al., 2000; Sutton et al., 2000; Wang et
al., 2001). Thereafter, caspase-3 permeabilizes mitochondria
primarily in a BH3-dependent fashion. The release of mito-
chondrial products then amplify the death process, ensuring
efficient execution of the cell. This pathway appears to repre-
sent the optimal sequence for cell death. However, the results
clearly indicate that mitochondria are not essential for the
granzyme-mediated killing. Independently of BH3 proteins,
caspase-3 induces DNA fragmentation presumably through
cleavage of ICAD (Wolf et al., 1999). If caspase-3 is lacking,
DNA fragmentation is conspicuously absent, suggesting a
pathway where the granzyme directly cleaves ICAD is not op-
erative in situ (Thomas et al., 2000). Finally, in the absence of
procaspase-3, activated caspase-7 produces mitochondrial in-
dependent nuclear condensation, emphasizing the crucial role
the caspases play in GrB-mediated apoptosis (Fig. 5).
There has been a resurgence in the notion that caspases act
as initiators and mitochondria as the amplifier of cell death
(Slee et al., 2000; Guo et al., 2002; Lassus et al., 2002;
Marsden et al., 2002). GrB originally served as an importantT
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tool to characterize the enzymology of caspases. Perform-
ing whole cell studies, we have learned from granzyme once
again that caspases influence mitochondrial integrity, thereby
augmenting the many facets of cell death.
Materials and methods
Cell lines
Jurkat cells were maintained in RPMI-1640 with 10% FBS (Atlanta Biologi-
cals). WT MCF-7, lacking caspase 3, (MCF-7wt), caspase-3–transfected
cells (MCF-7casp-3), and vector controls (MCF-7vec) were maintained (Yang
et al., 1998). WT and double negative (Bax, Bak) murine embryonic fibro-
blasts (Bax/Bak [ / ] MEFs) were generated and grown as described (Wei
et al., 2001). Jurkat cells overexpressing either empty vector or Bcl-2, Jur-
katvec, or JurkatBcl-2 were provided by Marcus Peter (University of Chicago,
Chicago, IL) (Stegh et al., 2002).
Reagents
L-glutamine, EDTA, glycerol, PFA, 3-aminopropyltrietoxy-silane, and pro-
pidium iodide were purchased from Sigma-Aldrich. RPMI 1640 was from
GIBCO BRL. GELCODE blue stain reagent and Hoechst 33342 were from
Pierce Chemical Co. and Molecular Probes, respectively. HRP rat anti–
mouse kappa mAb was from Accurate Chemical, and ready gels, silver
stain kit, Immunoblot and Sequiblot-PVDF membranes were purchased
from Bio-Rad Laboratories. ECL Western blot system and Hyperfilm ECL
and HRP-tagged anti–mouse and –rabbit secondary antibodies were from
Amersham Biosciences. Human GrB and PFN were isolated as described
(Hanna et al., 1993; Froelich et al., 1996b). Human serglycin (SG) was iso-
lated from supernatants of YT cells (Raja et al., 2002). The GrB inhibitor
Ac-IETD-cho was from Alexis Biochemicals. Z-DEVD-fmk and Z-VAD-fmk
were from Calbiochem. Anti–caspase-3 and -7, anti-PARP, and anti–cyt c
were from BD PharMingen, and anti-Bid was either provided by Dr. Xia-
odong Wang (University of Texas Southwestern Medical Center, Dallas,
TX) or obtained from Cell Signaling Technology. Antiactin antibody is from
ICN. Recombinant TRAIL was expressed as the cDNA fragment (aa 114–
281) in pET-23d plasmid.
Generation and analysis of GrB–SG complexes
GrB–SG complexes were prepared as reported previously (Metkar et al.,
2002). The concentrations of GrB retentates were assessed by ELISA
(Spaeny-Dekking et al., 1998). GrB enzymatic activity was measured using
Boc-Ala-Asp-thiobenzyl ester (BAADT) or Ac-Ile-Glu-Thr-Asp-pNA (IETD-
paranitroanilide; Calbiochem). Cleavage was monitored at 405 nm.
Protein delivery for induction of cell death
AD was employed at a plaque-forming unit (PFU) ranging from 500–1,000
per cell. The endosomolytic activity of the AD against the various target
cells was determined as follows: AD, containing the  -galactosidase con-
struct, was added to the designated target cell at increasing PFU/cell. The
cells were stained 18 h later for  -galactosidase expression. The PFU that
resulted in  80% positive target cells was used. GrB and GrB–SG were
used at 1 and 2  g/ml, respectively, for the experiments. Cells (10
6) were
treated for times indicated in the presence and absence of designated in-
hibitors and then processed for assays described below. Viability of treated
cells were comparable to media controls based on similar light scatter
characteristic and acquisition rates by flow cytometry.
Immunoblotting
Detection of processed caspase-3 and -7 and Bid was performed as re-
ported previously (Froelich et al., 1996a) with modifications described
here. 15 min before the completion of the assay, IETD-cho (250–500  M)
was added to targets. The cells were then incubated in solubilization buffer
(1% NP-40, 1 mM EDTA, 50 mM Tris-HCl, 165 mM NaCl) containing ad-
ditional IETD-cho. Thereafter, debris was cleared by centrifugation, and
the postnuclear lysate was immediately frozen ( 80 C) with aliquots held
to measure protein content. Each lot of IETD-CHO was evaluated for the
capacity to completely inactivate GrB in the lysates by measuring residual
GrB activity with the chromogenic substrate, IETD-pNA. For immunoblot-
ting, postnuclear lysates of varying protein content were thawed, mixed
with Laemelli buffer, heated, resolved by SDS-PAGE (10–15%), and trans-
ferred to Immunoblot PVDF membranes (Bio-Rad Laboratories). Signal was
visualized with the ECL kit (Amersham Biosciences).
Apoptosis assays
Hoechst assay. Cells were fixed in 4% PFA and dried on microscope slides.
For analysis, cells were hydrated, stained with Hoechst 33342 (10  g/ml),
and mounted with a drop of 50% glycerol in PBS. For each sample, 200
cells were counted to determine the percentage of cells with condensed
and/or fragmented nuclei.
FITC-TUNEL. Target cells (10
6/ml) were treated with the appropriate re-
agents in microfuge tubes for the required time and death was measured
by terminal deoxyribonucleotidyl transferase–catalyzed labeling of DNA
strand breaks with FITC-dUTP followed by flow cytometry (TUNEL).
PhiPhiLux caspase-3 assay. Cells were stained with the cell permeable
fluorogenic caspase 3 substrate PhiPhiLux (G1-D2; OncoImmunin, Inc.) as
per the manufacturer’s instructions followed by flow cytometry (Komoriya
et al., 2000).
FAM-DEVD-FMK caspase-3 assay. Cells were stained with the cell perme-
able fluorogenic caspase-3 inhibitor FAM-DEVD-FMK (APOLOGIX, Inc.)
as per the manufacturer’s instructions followed by flow cytometry.
Mitochondrial potential loss (  m)
After treatment, cells were stained with MitoTracker red CMXRos (Molecu-
lar Probes) as described (Metkar et al., 2000).
Imaging, computers, and software
Images of immunoblots were captured either with a Eastman Kodak digital
camera or Saphir Ultra 2 flatbed scanner, exported to Adobe Photoshop
®
Figure 5. Predominant and ancillary pathways for GrB-mediated 
apoptosis. After endocytosis, GrB–SG complexes are released to the 
cytosol where a portion of the intracellular stores of procaspase-3 is 
activated (dark gray arrows). The activated caspase then in a BH3-only/
Bax/Bak–dependent manner permeabilizes mitochondria, releasing 
cyt c and generating the caspase-9 apoptosome. Thereafter, caspase-9 
completes the amplification loop (black arrow) by cleaving additional 
procaspase-3. Light gray arrows describe hypothetical pathways 
where GrB–SG and caspase-3 perturb mitochondria in a BH3-
independent manner. Finally, white arrows describe sequential 
synergistic activation of procaspase-7 by GrB–SG and caspase-3, 
whereas light blue arrows describe nuclear condensation specifically 
by caspase-7 and cellular proteolysis by the caspases.T
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7.0, after which the Tiff images were placed for final presentation in Adobe
Illustrator
® 10.0 using a Macintosh Power G4 computer (OS X).
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